• PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial

    Jun 1, 2024, 00:00

  • MSR66 Development and Validation of Risk Prediction Tools for Pressure Injury Occurren An Umbrella Review

    Jun 1, 2024, 00:00

  • EE36 Comparison of Healthcare Resource Utilization and Costs in Patients With Venous Thromboembolism Receiving Direct-Acting Oral Anticoagulants or Low Molecular Weight Heparins: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EPH203 Cytomegalovirus Prevalence in Allogeneic Hematopoietic Stem Cell Transplant Recipients From a Mexican Oncologic Reference Center

    Jun 1, 2024, 00:00

  • EE385 Changes in Direct Costs of Breast Cancer in Colombia From 2011 to 2022

    Jun 1, 2024, 00:00

  • EPH168 Incidence of Pre-Dialysis Depression and Its Impact on Chronic Kidney Disease (CKD) Progression

    Jun 1, 2024, 00:00

  • CO157 Characteristics of Medicare Beneficiaries With Multiple Administrations of CAR-T Therapy

    Jun 1, 2024, 00:00

  • EE519 Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

    Jun 1, 2024, 00:00

  • EPH70 Real-World Second-Line Treatment Pattern and Disease Burden of Patients With Unresectable or Advanced Hepatic Carcinoma in China: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan

    Jun 1, 2024, 00:00

  • EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China

    Jun 1, 2024, 00:00

  • EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)

    Jun 1, 2024, 00:00

  • HPR50 How Do We Define Value in Health? Well, That Depends

    Jun 1, 2024, 00:00

  • CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks

    Jun 1, 2024, 00:00

  • SA6 Balancing Feasibility, Time, and Comprehensiveness: Approaches to Rapid Reviews of Health Economic Models

    Jun 1, 2024, 00:00

  • PCR84 Urinary Incontinence and Pelvic Organ Prolapse Knowledge Among Young Women Living in Hungary

    Jun 1, 2024, 00:00

  • CO147 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Entrectinib for Treatment of Metastatic Fusion-Positive Cancers in Children and Young Adults

    Jun 1, 2024, 00:00

  • AI and Machine Learning in HEOR

    Jun 1, 2024, 00:00

  • EPH229 Inequalities According to Health Regime, in the Survival of Colorectal Cancer in a Colombian Caribbean City

    Jun 1, 2024, 00:00

  • RWD81 Economic Impact of Epilepsy in Private Healthcare in Brazil

    Jun 1, 2024, 00:00

  • PCR70 Diagnostic Journey, Seizure Burden, and Quality of Life Among Patients With CDKL5 Deficiency Disorder Using Real-World Data

    Jun 1, 2024, 00:00

  • PCR103 Young People’s Preferences Towards Web-Based Mental Health Interventions for Anxiety and Depression: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • CO181 Upadacitinib in Moderate-to-Severe Crohn's Disease (CD): A Systematic Review of Remission Outcomes in Adults With Inadequate Response or Intolerance to Biologic Drugs

    Jun 1, 2024, 00:00

  • CO165 Changes in Mortality Rates With the Introduction of Immuno-Oncology Therapy in Advanced Non-Small Cell Lung Cancer: A Seer-Medicare Analysis

    Jun 1, 2024, 00:00

  • MT39 Reporting Characteristics of Randomized Controlled Trials of Endovascular Therapy for Peripheral Artery Disease: A Systematic Review

    Jun 1, 2024, 00:00

  • CO42 Disease Burden of Anal Carcinoma in Chinese Male Patients Under Current Care: A Model Simulation Study

    Jun 1, 2024, 00:00

  • HPR153 Improving Prediction of Medical Costs Among Medicare Beneficiaries By Incorporating Social Determinants of Health Indicators in Risk Prediction

    Jun 1, 2024, 00:00

  • CO65 Overall Survival in Metastatic NSCLC in HMO From Colombia: A Non-Interventional Study

    Jun 1, 2024, 00:00

  • HTA19 A Targeted Review of NICE, CADTH and ICER Assessments: An Evaluation of the Joint Position Statement

    Jun 1, 2024, 00:00

  • PCR5 Perceptions, Experiences, and Behaviors of Patients and Their Caregivers With Gastric and Gastroesophageal Cancer Treated With or Without Trastuzumab Deruxtecan (T-DXd) in the United States

    Jun 1, 2024, 00:00

  • PCR181 Predicting COVID-19 Vaccine Hesitancy through Integrated Protection Motivation Theory Constructs

    Jun 1, 2024, 00:00

  • EE408 Healthcare Costs Among Patients Diagnosed With Estrogen Receptor Positive (ER+) Breast Cancer: Relationship With Comorbid Depression and Adherence to Anti-Depressant Medication

    Jun 1, 2024, 00:00

  • HSD9 Oncology Practice Setting Classification in the US: Considerations for Real World Evidence

    Jun 1, 2024, 00:00

  • HSD106 Metastatic Colorectal Cancer (mCRC) Patients Treated with Later Lines of Treatment (LOT): A Retrospective Analysis By Race and Ethnicity in the United States (US) Community Oncology Setting

    Jun 1, 2024, 00:00

  • EPH164 Results and Impact of the Acceleration Plan Implementation for Maternal Mortality Reduction in the Department of Bolívar, Colombia

    Jun 1, 2024, 00:00

  • EE281 Cost-Effectiveness of Every Two Month Cabotegravir Long-Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Compared with Daily Oral Tenofovir Disoproxil Fumarate (TDF)/ Emtricitabine (FTC) As Prep to Prevent HIV-1 in the UK

    Jun 1, 2024, 00:00

  • HSD118 Real-World Treatment Patterns and Cardiovascular Disease (CVD) Burden in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Receiving Covalent Bruton’s Tyrosine Kinase Inhibitors (cBTKis)

    Jun 1, 2024, 00:00

  • CO172 Indirect Treatment Comparison of Efficacy and Safety of Capivasertib-Fulvestrant Versus Alpelisib-Fulvestrant for PIK3CA-Altered, HR-Positive, Advanced Breast Cancer after Disease Progression Following Endocrine-Based Therapy

    Jun 1, 2024, 00:00

  • PCR101 Characterizing the Experience of Caregiving for Those With Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • PCR214 Patients’ Preference and the Influencing Factors of Treatment Compliance in Chinese Patients With Maculopathy: A Qualitative Interview Research

    Jun 1, 2024, 00:00

  • EPH150 Post-Market Safety Assessment Associated with JAK Inhibitors of Xeljanz, Olumiant, and Rinvoq Using Faers Database from 2012 to 2022

    Jun 1, 2024, 00:00

  • EE295 Economic Burden Associated With Managing Patients With Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States

    Jun 1, 2024, 00:00

  • HPR98 Consumption of Hospital Resources in Intensive Care Units in Brazil: A Challenge for Health Financing

    Jun 1, 2024, 00:00

  • EE269 Direct Medical Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Colombia

    Jun 1, 2024, 00:00

  • EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia

    Jun 1, 2024, 00:00

  • HSD74 COVID-19's Impact on Healthcare Access for Arthritis Patients: Insights From the 2020 Medical Expenditure Panel Survey

    Jun 1, 2024, 00:00

  • PCR266 Patient Preferences for Continuous Glucose Monitoring Devices: A Preliminary Study from People Living with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • EE47 Cost Per Recurrence-Free Survivor (CPRS) and Cost Per Recurrence-Free Life Month (CPRLM) of Adjuvant Nivolumab (NIVO) Versus Pembrolizumab (PEMBRO) Among Patients With Resected Stage IIB/IIC Melanoma

    Jun 1, 2024, 00:00

  • Patient Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • RWD41 Adherence Trajectories in Medicaid Drug-Naïve Type 2 Diabetes Patients: A Comparative Study between Initial Combination Therapy and Step-Therapy Approaches

    Jun 1, 2024, 00:00

  • EPH72 Mortality From Diabetes Mellitus in the Department of Bolívar, Colombia: A 5-Year Analysis

    Jun 1, 2024, 00:00

  • EE271 Lifetime Productivity Loss Due to HIV Mortality in the United States

    Jun 1, 2024, 00:00

  • EE261 Costs and Outcomes Associated with COVID-19 Hospitalisation in the South African Public-Sector during the First-Wave

    Jun 1, 2024, 00:00

  • RWD180 Feasibility of Identifying Demographic and Clinical Insights for Patients with Chronic Kidney Disease from Real-World Data

    Jun 1, 2024, 00:00

  • SA59 Catalysts of Cost: Unveiling the Top Drivers of High-Cost Claims in Employer-Sponsored Healthcare Plans

    Jun 1, 2024, 00:00

  • Psychometric Properties of General Oral Health Assessment Index Across Ages: COSMIN Systematic Review

    Jun 1, 2024, 00:00

  • PCR121 Optimizing Drug Value and Access Using Implementation Science

    Jun 1, 2024, 00:00

  • PCR34 Higher Patient Activation Levels May Mitigate Alzheimer’s Caregiving Burden

    Jun 1, 2024, 00:00

  • EPH26 Claims-Based Analysis of the Prevalence, Characteristics, Healthcare Utilization, and Costs of Adolescents and Young Adults With Non-Remission Major Depressive Disorder in the United States, 2016-2022

    Jun 1, 2024, 00:00

  • EE500 Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

    Jun 1, 2024, 00:00

  • CO190 Lumbar Spine Problems Caused By Hyperextension and It's Prevention, As Well As Balance Development in Rhythmic Gymnasts

    Jun 1, 2024, 00:00

  • EPH133 Economic Burden of Invasive Meningococcal Disease in Individuals With Commercial and Medicare Insurance in the United States

    Jun 1, 2024, 00:00

  • EPH212 Assessing Intersectional Differences in Myocardial Infarction Among Same Race/Ethnicity Transgender and Cisgender Adults Using 2017-2022 Behavioral Risk Factor Surveillance System Data

    Jun 1, 2024, 00:00

  • RWD114 Economic Burden, Treatment Utilization, and Medication Adherence of Post-Traumatic Stress Disorder (PTSD) Patients: A Retrospective Commercial and Medicare Part B Insurance Claims Analysis

    Jun 1, 2024, 00:00

  • EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023

    Jun 1, 2024, 00:00

  • SA75 Assessing the Value of Linking Abstracted Medical Record Data With Administrative Claims Data to Study Patients With High-Risk Non-Muscle Invasive Bladder Cancer in the United States

    Jun 1, 2024, 00:00

  • PCR111 Real-World Evidence on Adherence to the First CDK 4/6 Inhibitor (Palbociclib) in Breast Cancer Patients From Romania

    Jun 1, 2024, 00:00

  • PCR198 Assessing the Additional Value of Negative Multi-Cancer Early Detection (MCED) Tests: Results from an Online Survey of the General Population

    Jun 1, 2024, 00:00

  • P30 Semi-Markov Model (sMM) Versus Trial-Level Surrogacy to Predict Overall Survival (OS) for Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC) with Chemotherapy

    Jun 1, 2024, 00:00

  • EPH125 Geographic Disparities in Chronic Kidney Disease Hospitalizations: Exploring Associations with Neighborhood Socioeconomic Status in Texas

    Jun 1, 2024, 00:00

  • CO14 Profiling Adverse Events in Multiple Myeloma: Insights from Clinical Trials Via Large Language Models

    Jun 1, 2024, 00:00

  • EE503 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Healthcare Costs (HCC) of Patients with Small-Cell Lung Cancer (SCLC) in the US

    Jun 1, 2024, 00:00

  • EE107 Long-Term Cost-Effectiveness of iGlarLixi Versus IDegLira in Patients With Uncontrolled Type 2 Diabetes Treated With Basal Insulin or Oral Antidiabetic Drug in China

    Jun 1, 2024, 00:00

  • PCR127 Patients' Preference in Intravitreal Treatment Options for Diabetic Macular Edema: Insights from Discrete Choice Experiment and Willingness to Pay

    Jun 1, 2024, 00:00

  • RWD61 Characterization of SLE Patient Population from the FORWARD Lupus Registry (FLR) in the US

    Jun 1, 2024, 00:00

  • CO173 The Role of Mindfulness, Pelvic Floor Physical Therapy (PFPT), and Hypopressive Exercises for Chronic Pelvic Pain (CPP): Preliminary Results in Productivity Gain and Loss

    Jun 1, 2024, 00:00

  • PCR173 Health State Utilities Associated With X-Linked Retinitis Pigmentosa in the United States

    Jun 1, 2024, 00:00

  • RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor

    Jun 1, 2024, 00:00

  • RWD116 Navigating the Currents of the Pandemic: A Comprehensive Analysis of Medicare Data Reflecting COVID-19's Impact on Cardiovascular Disease Healthcare Utilization

    Jun 1, 2024, 00:00

  • CO80 Using Machine Learning to Understand Predictors of Frequent Surveillance Testing in Colorectal Cancer Patients

    Jun 1, 2024, 00:00

  • CO117 Factors Associated with Biologic Treatment De-Escalation in Patients with Crohn’s Disease

    Jun 1, 2024, 00:00

  • HPR34 The Effect of Medical Insurance Outpatient Pooling Policy on Medical Service Utilization of Insured People: Evidence from CHARLS

    Jun 1, 2024, 00:00

  • EPH235 Impact of Real-Time Containment Measures on COVID-19 Pandemic Outcomes in African Countries

    Jun 1, 2024, 00:00

  • HTA47 Assessing the Effectiveness and Cost of Future Technologies to Screen for Colorectal Cancer

    Jun 1, 2024, 00:00

  • HSD44 Association of Penicillin Allergy Documentation and First-Line Penicillin Prescribing for Common Infections in Primary Healthcare Facilities in Beijing

    Jun 1, 2024, 00:00

  • PCR94 A Systematic Literature Review of Quality-of-Life Outcomes in Posttraumatic Stress Disorder (PTSD)

    Jun 1, 2024, 00:00

  • CO162 Systematic Literature Review (SLR) and Meta-Analysis of Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ROS-1 Rearranged Non-Small Cell Lung Cancer

    Jun 1, 2024, 00:00

  • SA33 Real-World Comparison of Adherence and Persistence between Glucagon-like Peptide-1 Receptor Agonist (GLP-1) and Sodium-Glucose Cotransporter 2 (SGLT-2) in Patients with Type 2 Diabetes (T2D)

    Jun 1, 2024, 00:00

  • PCR248 Comparison of Quality of Life Scales after Stroke in Hungarian and International Practice

    Jun 1, 2024, 00:00

  • CO159 Evaluating Risk of Complications in CAR-T Cell Therapy Among Patients with Acute Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • RWD132 Do Generic Population Utility Scores Accurately Represent Real-World Experienced Health?

    Jun 1, 2024, 00:00

  • HTA81 Assessing Evidence Packages of CRISPR Technologies: Will They Meet Payer Needs?

    Jun 1, 2024, 00:00

  • PCR141 Smoldering Multiple Myeloma: A Multi-Country Mixed-Methods Study on Disease Perceptions and Patient Treatment Preferences

    Jun 1, 2024, 00:00

  • CO198 Exploring Progression-Free Survival 2 (PFS2) Endpoint Trends and Uptake in the US Healthcare Landscape

    Jun 1, 2024, 00:00

  • OP6 Plain Language Summaries in Medical Journals – How Accessible Is Scientific Research to the General Public?

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • EPH78 Lung Cancer Screening Eligibility and Use in the US: A Cross-Sectional Analysis of 2022 Behavioral Risk Factor Surveillance System Data

    Jun 1, 2024, 00:00

  • EPH128 Identifying Diabetic Ketoacidosis Events at Diagnosis Among Type 1 Diabetes Patients in Claims Data

    Jun 1, 2024, 00:00

  • MSR25 An Assessment of ChatGPT's Ability to Code for Different Statistical Packages

    Jun 1, 2024, 00:00

  • HPR55 Limiting the Potency of Delta-9-Tetrahydrocannabinol (THC) in Cannabis Products: What Policymakers Need to Know

    Jun 1, 2024, 00:00

  • HPR6 Inflation Reduction Act: How Will the First 10 Drugs Selected for Medicare Price Negotiations Impact US Commercial Payers?

    Jun 1, 2024, 00:00

  • HPR94 Clinical Trial Engagement in Hepatocellular Carcinoma: Understanding Demographic and Clinical Characteristics

    Jun 1, 2024, 00:00

  • EE286 Japan-Specific Risk Equations for Modeling Diabetes in the Japanese Setting: Does It Make a Difference?

    Jun 1, 2024, 00:00

  • PT38 Early and Mid-Term Outcome of Valve Replacement With Porcine Bioprosthesis in the Aortic Positions

    Jun 1, 2024, 00:00

  • CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes

    Jun 1, 2024, 00:00

  • PCR67 Exploring the Link Between Genomic Testing Decisions and Quality of Life When Diagnosing Rare Childhood Disorders: A Sequential Stated Choice Experiment

    Jun 1, 2024, 00:00

  • EE520 Cost-Effectiveness of Tremelimumab Plus Durvalumab for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma in the United States

    Jun 1, 2024, 00:00

  • EPH112 Prevalent Comorbidities and Disease-Related Conditions in Heavily Pre-Treated Patients With Multiple Myeloma: A Real-World Retrospective Database Analysis

    Jun 1, 2024, 00:00

  • HPR132 Employer Perspectives on Alternative Funding Programs

    Jun 1, 2024, 00:00

  • EE84 Budget Impact of Factor VIII Treatments for Hemophilia A in the United States

    Jun 1, 2024, 00:00

  • PCR36 Substantial Productivity Impairment in Patients With Essential Tremor

    Jun 1, 2024, 00:00

  • EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study

    Jun 1, 2024, 00:00

  • CO139 Comparative Effectiveness of Rapid Vs. Non-Rapid Start of Anti-Retroviral Therapy in Patients With Human Immunodeficiency Virus Infection on Clinical Outcomes: A Systematic Literature Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • RWD2 Comparison of Availability of New Cancer Medicines between Seven Countries

    Jun 1, 2024, 00:00

  • PCR185 Health As a Value in University Students

    Jun 1, 2024, 00:00

  • EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown

    Jun 1, 2024, 00:00

  • Addressing Confounding in Real-World Evidence Studies

    Jun 1, 2024, 00:00

  • RWD169 Prevalence of ANCA-Associated Vasculitis in Adults in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • MT13 Comprehensive Assessment for Breast Cancer Diagnosis Employing MATLAB Pre-Trained Models with Machine and Deep Learning

    Jun 1, 2024, 00:00

  • EE188 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in the United States

    Jun 1, 2024, 00:00

  • EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan

    Jun 1, 2024, 00:00

  • RWD91 Healthcare Resource Utilization and Costs Associated with COVID-19 in Colombia: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • RWD149 Real-World Endometrial Cancer Mortality Outcomes at Brazilian Reference Women Healthcare Public Hospital

    Jun 1, 2024, 00:00

  • EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients

    Jun 1, 2024, 00:00

  • RWD86 Impact of Population Aging on the Colombian Health System: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HSD70 Characteristics of Medicare Patients Initiating Long-Acting Injectable Antipsychotic Medications

    Jun 1, 2024, 00:00

  • MT37 FDA-Approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An Updated Landscape from 1995 to 2023

    Jun 1, 2024, 00:00

  • EE142 A Cost Utility Analysis of Zuranolone in the Treatment of Major Depressive Disorder

    Jun 1, 2024, 00:00

  • P40 Caregivers’ Stated and Revealed Preferences for Antipsychotic Medication Use Among Youth: A Discrete Choice Experiment of Benefit-Risk Trade-Offs

    Jun 1, 2024, 00:00

  • PCR249 Understanding Caregiver Burden from Multiple Perspectives: Dyadic Agreement between Caregiver and Care Recipient

    Jun 1, 2024, 00:00

  • PCR158 Assessing the Cost of Work Productivity Loss in a Privately Insured US Population With Inflammatory Bowel Diseases

    Jun 1, 2024, 00:00

  • EE332 Cost-Effectiveness Analysis of Implementing a Field Hospital during a Pandemic

    Jun 1, 2024, 00:00

  • RWD151 Knowledge Management Tool: A Large Language Model-Based Search Engine

    Jun 1, 2024, 00:00

  • HPR63 Research and Development (RD) Investment By the Biopharmaceutical Industry: A Global Ecosystem Update

    Jun 1, 2024, 00:00

  • EE256 Cost-Effectiveness of Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anemia in Pregnant Women

    Jun 1, 2024, 00:00

  • RWD182 AI-Assisted Chart Review to Understand Disease Flares in Systemic Lupus Erythematosus

    Jun 1, 2024, 00:00

  • HSD60 Self-Reported Pain Severity and Opioid Utilization in Adult Patients with Spine-Related Problems

    Jun 1, 2024, 00:00

  • SA69 Enhancing the Value and Usefulness of Data Extracted From an Economic Systematic Literature Review

    Jun 1, 2024, 00:00

  • CO196 Saturation Reporting in COA Development and Validation Studies: A Scoping Overview

    Jun 1, 2024, 00:00

  • EE129 Tools for the Critical Appraisal of Health Economic Analyses: A Scoping Review

    Jun 1, 2024, 00:00

  • MT44 Handheld Robotically Assisted Primary Unilateral Total Knee Arthroplasty (R-TKA) Demonstrates Lower Short-Term Costs and Length of Stay Compared to Conventional Instrumentation TKA (C-TKA)

    Jun 1, 2024, 00:00

  • HPR24 Understanding Pharmacy Benefit Manager (PBM) Adoption of Humira Biosimilars and Identifying Their Preferred Humira Biosimilars in Comparison with Humira

    Jun 1, 2024, 00:00

  • CO170 Real-World Survival Outcomes in Patients with Intermediate-to-High-Risk Non-Muscle Invasive Bladder Cancer Utilizing Medicare Claims Data: Estimating Event Free Survival and Evaluating Its Prediction of Overall Survival

    Jun 1, 2024, 00:00

  • EPH94 Healthcare Access and Health Equity Outcomes Among Adults With Cardiometabolic Conditions

    Jun 1, 2024, 00:00

  • HTA75 Utilization of Artificial Intelligence By Health Technology Assessment Agencies to Improve Efficiency of Health Technology Appraisals

    Jun 1, 2024, 00:00

  • EE161 The Economic Burden of BRCA+ Metastatic Castration Resistant Prostate Cancer: Expert Perspective in LATAM Countries

    Jun 1, 2024, 00:00

  • HPR57 Use of External Control Arms in Novel Drug Approvals By U.S. Food and Drug Administration: A Targeted Review

    Jun 1, 2024, 00:00

  • HPR75 Can Multi-Cancer Early Detection Screening Result in Early Cancer Detection? A Modeling Study

    Jun 1, 2024, 00:00

  • HSD73 Neoadjuvant Adjuvant Therapy for Early-Stage/Resectable Non-Small Cell Lung Cancer (NSCLC): Physician Practices, Therapy Choice, and Challenges Among US Oncologists

    Jun 1, 2024, 00:00

  • EE91 Clinical Consequences and Associated Costs of Treating Patients With Chronic Lymphocytic Leukemia (CLL) With Bruton Tyrosine Kinase Inhibitors (BTKis) in the First-Line (1L) and Relapsed/Refractory (R/R) Settings

    Jun 1, 2024, 00:00

  • Cover

    Jun 1, 2024, 00:00

  • PCR91 Patient Perspectives on Treatment Effectiveness in Psoriatic Arthritis: A Pilot Qualitative Study to Understand What Matters Most

    Jun 1, 2024, 00:00

  • EE426 Cost-Comparison Analysis of Non-Invasive Testing Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Veteran Population

    Jun 1, 2024, 00:00

  • EE304 Healthcare Resource Utilization and Cost of Care of Different IV Iron Treatments in Heart Failure Patients Diagnosed With Iron Deficiency/Iron Deficiency Anemia Using a Real-World Database

    Jun 1, 2024, 00:00

  • RWD80 Identification and Characterization of Real-World Evidence Presented on Brand Websites for the Top 20 Medicines with the Highest CMS Expenditure

    Jun 1, 2024, 00:00

  • HTA37 Digital Health Value Assessment Frameworks: An International Landscape

    Jun 1, 2024, 00:00

  • EPH59 A Systematic Review on the Health Equity Disparities in Lupus Treatment: Medicaid Vs. Private Payer Outcomes

    Jun 1, 2024, 00:00

  • EE130 Economic Burden of Seasonal Influenza in Mainland China from 2011 to 2019

    Jun 1, 2024, 00:00

  • CO191 Improving Shooting Accuracy and Center of Gravity with Closed Kinematic Chain Exercises in Handball Players

    Jun 1, 2024, 00:00

  • PT21 A Generalized Framework for Eliciting Unreported Subgroup-Specific Events and Survival Outcomes from Aggregate Level Data: Analyses Advanced Stage Gastrointestinal Cancers

    Jun 1, 2024, 00:00

  • RWD30 Ways To Minimize Data Quality Headaches in Migraine Research

    Jun 1, 2024, 00:00

  • EPH167 Real-World Treatment Patterns, Sequencing, and Unmet Need in Metastatic Colorectal Cancer (mCRC)

    Jun 1, 2024, 00:00

  • EE177 The Cost-Effectiveness Analysis of Anaprazole Versus Ilaprazole for Treating Duodenal Ulcers in China

    Jun 1, 2024, 00:00

  • P46 Can Large Language Models Simulate HTA Committee Discussions? Findings and Challenges from a Case Study in Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer

    Jun 1, 2024, 00:00

  • HSD92 Clinical Outcomes of Patients With Obesity in a US Employer-Funded Medical Weight Management Program: A Pilot Study

    Jun 1, 2024, 00:00

  • PCR247 Multidimensional Examination of Factors Determining Body Image Among Women of Reproductive Age in Hungary

    Jun 1, 2024, 00:00

  • EE446 Economic Burden of Mild or Moderate Asthma in Pediatric Patients from the Perspective of Public Health Institutions in Mexico

    Jun 1, 2024, 00:00

  • EPH160 A Risk Stratification Analysis of ASCVD Events Post-Statin Discontinuation in Bariatric Surgery Patients

    Jun 1, 2024, 00:00

  • MT26 HTA Requirements for Medical Technologies in Canada

    Jun 1, 2024, 00:00

  • Pricing and Regulatory Policies: Implications for Pharmaceutical Manufacturers

    Jun 1, 2024, 00:00

  • CO48 A Non-Interventional Chart Review Study of Infliximab Precision-Guided Dosing Tool's Clinical Experience Program: Interim Analysis of Real-World Health Outcomes and Extrapolated Cost Savings

    Jun 1, 2024, 00:00

  • EE435 Hospitalization Costs of Common Grade 3/4 Adverse Events Associated With Oncology Treatments in the United States

    Jun 1, 2024, 00:00

  • HSD85 The Power of Click on Pharma Consumer: Navigating the Evolution and Challenges of Drug E-Commerce

    Jun 1, 2024, 00:00

  • PCR239 Perspectives on Pre-Exposure Prophylaxis (PrEP) Among People Who Could Benefit From PrEP: Qualitative Research Findings

    Jun 1, 2024, 00:00

  • EPH66 Pre-Exposure Prophylaxis Adherence Trajectories and HIV and Sexually Transmitted Infections Risk

    Jun 1, 2024, 00:00

  • EE260 Economic Analysis of a Low-Threshold Mobile Medical Unit Dispensing Buprenorphine for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials

    Jun 1, 2024, 00:00

  • PCR244 Prevalence of Plain-Language Summaries (PLS) in Open Access Patient-Reported Outcome (PRO) Publications

    Jun 1, 2024, 00:00

  • EPH233 Exploring Disparities in Prep Prescriptions for High-Risk HIV Patients Using Real-World Data

    Jun 1, 2024, 00:00

  • Health Equity Considerations in Economic Evaluations

    Jun 1, 2024, 00:00

  • MSR84 Understanding How Baseline Risk Affects Treatment Outcomes in Clinical Trials: Exploring Key Factors

    Jun 1, 2024, 00:00

  • EE320 Budget Impact Analysis of TPMT and NUDT15 Pharmacogenomic Testing for 6-Mercaptopurine in Pediatric Acute Lymphocytic Leukemia Patients

    Jun 1, 2024, 00:00

  • SA9 Validation of a Claims-Based Algorithm to Identify Major Congenital Malformations in Infants Using a Linked Claims-EMR Database

    Jun 1, 2024, 00:00

  • HPR127 Examine the Use of Real-World Evidence To Support FDA Decision-Making for New Drug Applications and Biologics License Applications From 2021 to 2022

    Jun 1, 2024, 00:00

  • EE266 The Economics Promises of a Cure: Best Practices to Guide Economic Negotiations for the Reimbursement of Curative Therapies for Cancer

    Jun 1, 2024, 00:00

  • PCR186 Understanding the Participant Experience of Qualitative Interview Studies To Inform Future Study Design: Analysis of Feedback Forms

    Jun 1, 2024, 00:00

  • MSR95 Artificial Intelligence for Targeted Literature Review Screening within the Rayyan Platform

    Jun 1, 2024, 00:00

  • P15 A Review of Methods and Guidance for Considering Equity in Health Economic Research

    Jun 1, 2024, 00:00

  • RWD18 Healthcare Costs Associated With Type 1 Diabetes in Adults With a Commercial, Medicaid, or Medicare Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • EE82 Health Care Resource Use Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • EPH195 Social and Political Correlates of Geographic Disparities in HIV and Cardiovascular Medication Utilization

    Jun 1, 2024, 00:00

  • CO32 Predictors of Overall Survival (OS) and Time to Next Treatment (TTNT) in Real-World Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Patients Who Received First-Line (1L) Folfirinox (FFX) or Gemcitabine + Nab-paclitaxel (GnP)

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • EE49 Public Health Impact and Cost-Effectiveness of a New Dengue Vaccine (TAK-003) in a Large Catch-up Cohort in Puerto Rico

    Jun 1, 2024, 00:00

  • CO51 Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma

    Jun 1, 2024, 00:00

  • EE311 Exploring Environmental Impacts of Switching Salmeterol/Fluticasone Propionate (SAL/FP) from Metered Dose Inhaler (MDI) to Dry Powder Inhaler (DPI) in Respiratory Illness in the United Kingdom

    Jun 1, 2024, 00:00

  • HSD128 Opioid Utilization in Rheumatoid Arthritis: Changes in Opioid Use after Advanced Therapy Initiation and Its Moderators

    Jun 1, 2024, 00:00

  • PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • HSD100 Effectiveness of Data-to-Care Proactive Adherence Interventions on Retention and Relinkage to HIV Care Amid COVID Pandemic

    Jun 1, 2024, 00:00

  • SA51 A Non-Systematic Literature Review of Literature Reviews: Evaluation of Methods Implemented and Language Used to Describe Systematic and Non-Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • PCR201 Understanding the Patient Experience With High Cholesterol in the United States: A Patient-Community-Led Qualitative Study

    Jun 1, 2024, 00:00

  • RWD190 The Impact of a Colorectal Cancer Diagnosis on Health Resource Utilization Patterns Among Patients With Hypertension Using Real-World Data

    Jun 1, 2024, 00:00

  • HSD62 Real-World Treatment Patterns in the Metastatic Hormone-Sensitive Prostate Cancer Setting Across Europe

    Jun 1, 2024, 00:00

  • EE191 Economic Evaluation of Mental Health Interventions: A Cost-Consequence Analysis

    Jun 1, 2024, 00:00

  • CO197 Vaso-Occlusion Definitions Can Impact Efficacy Assessments in Clinical Studies of Sickle Cell Disease

    Jun 1, 2024, 00:00

  • HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia

    Jun 1, 2024, 00:00

  • EE285 Economic Burden of Gestational Diabetes: A Global Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE352 Economic Burden of Prostate Cancer in the US: A Disease Stage-Based Cost Analysis

    Jun 1, 2024, 00:00

  • HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists

    Jun 1, 2024, 00:00

  • P44 Cost-Effectiveness of Eliglustat Tartrate for the Treatment of Type 1 Gaucher Disease in China Using a Semi-Markov Model

    Jun 1, 2024, 00:00

  • RWD140 Obeticholic Acid for Primary Biliary Cholangitis: Modeling Prevention of Clinical Events Using Real-World Data

    Jun 1, 2024, 00:00

  • HSD95 Utilization of Prescription Acquisition by Drive-Thru and Mail Before and During the COVID-19 Pandemic in the United States

    Jun 1, 2024, 00:00

  • HPR3 Exploring the Inequity of HRQoL in Individuals With Long COVID Symptoms

    Jun 1, 2024, 00:00

  • EE405 Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa

    Jun 1, 2024, 00:00

  • EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada

    Jun 1, 2024, 00:00

  • HPR81 Multi-Stakeholder Approach to Rare Disease Care in Latin America

    Jun 1, 2024, 00:00

  • CO107 Assessing Short and Long-Term Outcomes in Drug-Associated Acute Kidney Injury

    Jun 1, 2024, 00:00

  • PCR132 Disparities in Patient Reported Outcomes Completion Rates and Baseline Function in Newly Presenting Spine Patients

    Jun 1, 2024, 00:00

  • CO112 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Ruxolitinib Cream 1.5% Vs Other Pharmacologic Agents in the Treatment of Atopic Dermatitis (AD)

    Jun 1, 2024, 00:00

  • RWD20 Enhancing Oncology Model: Discordance Among Patients Using Intravenous Iron in the US

    Jun 1, 2024, 00:00

  • HSD82 A Technology-Enabled Model to Define the Total Costs of Comprehensive Management of Hip and Knee Osteoarthritis: The Missing Link in Value Based Musculoskeletal Care

    Jun 1, 2024, 00:00

  • EE277 Budget Impact Analysis of Anaprazole for the Treatment of Duodenal Ulcer in China

    Jun 1, 2024, 00:00

  • HPR17 Exploring Financing Models for CAR-T Cell Therapies in Global Healthcare Systems: A Comprehensive Scoping Review

    Jun 1, 2024, 00:00

  • P19 Negative Control Outcomes (NCOs) to Assess Comparability of Psoriasis (PsO) and Psoriatic Arthritis (PsA) Treatments

    Jun 1, 2024, 00:00

  • RWD4 A Real-World Data Landscape Review of the 2023 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference

    Jun 1, 2024, 00:00

  • PCR207 Health-Related Quality of Life and Its Associate Factors Among Residents in Tianjin, China: Findings from 2023 National Health Service Survey

    Jun 1, 2024, 00:00

  • OP8 Justice-Informed Analysis: A Unified Framework for Increasing Inclusivity and Methodological Rigor in Health Inequities Research

    Jun 1, 2024, 00:00

  • EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan

    Jun 1, 2024, 00:00

  • PCR28 Baseline Characterization of Patient-Reported Disease Burden in a Virtual, Longitudinal Cohort of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • Understanding the National Institute for Health and Care Excellence Severity Premium: Exploring Its Implementation and the Implications for Decision Making and Patient Access [Editor's Choice]

    Jun 1, 2024, 00:00

  • RWD39 Validating the Utility of Synthetic Data Generation for Clinical Research

    Jun 1, 2024, 00:00

  • EE38 Impact of Expenditure on Medicines for STD/AIDS on the Instituted Budget after the End of the Regime That Established a Ceiling on Public Expenditure in Brazil

    Jun 1, 2024, 00:00

  • HTA22 Assessing Cost-Savings From the Inflation Reduction Act in Louisiana Medicare Beneficiaries Due to Diabetes Medications

    Jun 1, 2024, 00:00

  • P59 A Microsimulation Model for High-Risk Stage II and Stage III Colon Cancer Survivors Following the Current Guidelines

    Jun 1, 2024, 00:00

  • RWD177 Treatment Pattern and Disease Burden of Severe Asthma: A Real-World Study Based on Claims Data in China

    Jun 1, 2024, 00:00

  • EPH172 Humanistic and Economic Burden Among COPD Patients in China: How Does It Compare With Other Common NCDs?

    Jun 1, 2024, 00:00

  • CO77 A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients with Muscle Invasive Bladder Cancer

    Jun 1, 2024, 00:00

  • EE181 Impact of Type 1 Diabetes on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitoring Users in the United States: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • CO131 Exploring Simplified Screening Cut-Offs: Classification of KCNQ2-DEE Patients into Age-Adjusted Disease Phenotypes

    Jun 1, 2024, 00:00

  • RWD101 Leveraging Ways of Working and Innovation Methodologies from the Technology Sector to Inform New Approaches to Health Equity Initiatives

    Jun 1, 2024, 00:00

  • CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older

    Jun 1, 2024, 00:00

  • PCR13 Bridging the Gap: User Engagement in Developing and Implementing Digital Medication Adherence Technologies

    Jun 1, 2024, 00:00

  • EPH71 Trend of Increase in the Use of Hormonal Intrauterine Devices in Women From a Health Insurance Company in Brazil: What Is the Explanation?

    Jun 1, 2024, 00:00

  • EPH218 The Clinical and Economic Epidemiology of Breast Cancer in Brazil from 2016 to 2022: A Real-World Evidence Study of 295,000 Outpatients in Public System

    Jun 1, 2024, 00:00

  • EE31 The Annual Economic Burden of PFO-Related Cryptogenic Stroke in the U.S.: A Cost-of-Illness Study

    Jun 1, 2024, 00:00

  • EE358 Systematic Literature Review of Cost-Effectiveness Analyses of Adult 15- and 20-Valent Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • EPH92 A Targeted Literature Review on Medication Adheren A Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Study

    Jun 1, 2024, 00:00

  • EE393 Assessing Cost-Effectiveness in Diabetes Management: A US Healthcare Payer’s Perspective on 15MG Tirzepatide Versus 1MG Semaglutide

    Jun 1, 2024, 00:00

  • EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease

    Jun 1, 2024, 00:00

  • RWD123 Clinical and Hospital Related Outcomes of Journey II Knee System Compared to Other Knee Systems in the Management of Total Knee Arthroplasty (TKA) Patients

    Jun 1, 2024, 00:00

  • EE468 Cost-Effectiveness Study of the Use of Fibrinogen Concentrate (Clottafact®) in Patients with Major Bleeding and Trauma Requiring Surgery in Mexican Public Health Institutions

    Jun 1, 2024, 00:00

  • EE60 The Excessive Burden of Low SES Caregivers: Evidence from Stroke Survivors Through CHARLS Data (2011-2018)

    Jun 1, 2024, 00:00

  • EE58 Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements in Lower-Middle Income Countries in Asia

    Jun 1, 2024, 00:00

  • EPH181 Real World Retrospective Analysis of Short-Term Disability Claims for the Genitourinary System in the United States

    Jun 1, 2024, 00:00

  • MT27 Comparison of Quality Parameters from Control Units Processed with Semi-Automated and Automated Processing Systems in the Colombian Blood Bank Hospital Pablo Tobón Uribe

    Jun 1, 2024, 00:00

  • CO79 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How Did It Change in 2022 and 2023?

    Jun 1, 2024, 00:00

  • HPR65 Assessing Rare Disease Reimbursement Levels and Economic Burden on Patients in China

    Jun 1, 2024, 00:00

  • HSD64 Data Visualization of Patterns of Adjuvant Endocrine Therapy Among Older Women With Hormone-Positive Early-Stage Breast Cancer

    Jun 1, 2024, 00:00

  • HPR51 Use of Real World Evidence in 2023 Novel Drug Approvals

    Jun 1, 2024, 00:00

  • CO36 Evaluating the Impact of State Level Masking Policies on Adherence over Time in Diabetic and Hypertensive Populations

    Jun 1, 2024, 00:00

  • EPH51 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in China: A Real-World, Contemporary Cohort Study

    Jun 1, 2024, 00:00

  • EPH87 Invasive Meningococcal Disease Risk Factors in Individuals With Commercial and Medicare Insurance in the United States

    Jun 1, 2024, 00:00

  • HTA44 Systematic Literature Review Requirements for Health Technology Assessment in European Markets

    Jun 1, 2024, 00:00

  • CO93 Impact of Caring for Persons with Schizophrenia: Review of Burden Assessment Measures

    Jun 1, 2024, 00:00

  • CO113 The Financial Effect of Closing the Hypertension Blood Pressure Care Gap at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • RWD33 An Overview of Real-World Studies on Central Nervous System Diseases in China: A Decade of Data and Insights

    Jun 1, 2024, 00:00

  • EPH5 COVID-19 Vaccine Acceptance Disparities Among Foreign-Born and US-Born Individuals in California: A 2021 Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • PCR254 Evidence To Support the Use of the Functional Assessment of Cancer Therapy – General Item GP5 (FACT-GP5) To Assess Comparative Tolerability Endpoint: Results From the LIBRETTO-531 Trial

    Jun 1, 2024, 00:00

  • P22 Measuring Health-Related Quality of Life during Pregnancy: Exploring the Psychometric Properties of PROMIS to Assess Health-Related Quality of Life

    Jun 1, 2024, 00:00

  • EE170 Social and Clinical Factors Influencing ED Utilization Behavior Amongst Blue Cross Blue Shield of Louisiana Members: A Cluster Analysis

    Jun 1, 2024, 00:00

  • HSD26 Descriptive Landscape for Precision Medicines in Second-Line Biliary Tract Cancer: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • HSD67 A Retrospective Study Assessing Clinical and Economic Impacts of a Multidisciplinary Approach for Reducing Risk of Catheter-Related Thrombosis in a U.S. Health System

    Jun 1, 2024, 00:00

  • EE419 The Economic Burden of Thyroid Eye Disease in the Kingdom of Saudi Arabia

    Jun 1, 2024, 00:00

  • HTA59 Reception of RWE: A Deep Dive Into Recent Trends in CADTH Reimbursement Reviews

    Jun 1, 2024, 00:00

  • EE186 Trends in Cost of Treatment with Immuno-oncology Drugs in the US

    Jun 1, 2024, 00:00

  • HSD6 The Role of Market Access Professionals in Pharmaceutical Industry: Document Analysis

    Jun 1, 2024, 00:00

  • EE135 Clinical and Economic Burden of Obesity in Low- and Middle-Income Countries: A Systematic Review

    Jun 1, 2024, 00:00

  • HSD123 Prescription Opioid Dispensings in Medicare Part D in 2020 by US Region and Prescriber Type

    Jun 1, 2024, 00:00

  • HTA73 Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL)

    Jun 1, 2024, 00:00

  • CO201 Feasibility of Using Positron Emission Tomography–Computed Tomography (PET-CT) Scans From Real-World Medical Record Data to Support Lymphoma Treatment Response Assessment

    Jun 1, 2024, 00:00

  • P24 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

    Jun 1, 2024, 00:00

  • HPR104 How Well Can Insurers Police Off-Label Use? Evidence from GLP-1s in Medicare Part D

    Jun 1, 2024, 00:00

  • EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data

    Jun 1, 2024, 00:00

  • PCR217 Diagnosing Preferences to Facilitate Shared Decision-Making: Development of a Novel Preference-Based Decision Support Tool for Adult Patients with Eosinophilic Esophagitis

    Jun 1, 2024, 00:00

  • SA35 Assessing Meta-Analyses and Systematic Literature Reviews Comparing Effectiveness of Treatments for Relapsed/Refractory Multiple Myeloma (RRMM): A Targeted Literature Review From 2017-2023

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • PCR74 Health Expectations and Costs of People with Autism and Their Families

    Jun 1, 2024, 00:00

  • EE51 Analysis of Direct Costs of Treating Severe Hemophilia A in Brazil

    Jun 1, 2024, 00:00

  • RWD67 Influenza's Impact on Heart Failure Patients: A Ten-Year Analysis

    Jun 1, 2024, 00:00

  • SA27 Reduction in Corticosteroid Use Among Patients With Focal Segmental Glomerulosclerosis, Membranous Nephropathy, or IgA Nephropathy after Acthar® Gel in a Large Administrative Claims Database

    Jun 1, 2024, 00:00

  • HPR145 Anti-VEGF Molecule Utilization in Ophthalmology and Potential Impact of Market Dynamics after Biosimilar Entry

    Jun 1, 2024, 00:00

  • EE275 Cost-Effectiveness Analysis of Biologics Used for the Treatment of Ankylosing Spondylitis in China

    Jun 1, 2024, 00:00

  • EE458 Economic Burden of Disease Recurrence in Elderly Patients With Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Early Breast Cancer (eBC)

    Jun 1, 2024, 00:00

  • PCR38 Health-Related Quality of Life Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • CO85 Longitudinal Patterns of Loss of Independence in Parkinson Disease

    Jun 1, 2024, 00:00

  • EE283 Cost-Effectiveness Analysis of NRICM101 Compared to Usual Care for Treating COVID-19

    Jun 1, 2024, 00:00

  • EE354 Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • EE78 Economic and Comorbidity Burden of Prurigo Nodularis and Drivers of Higher Healthcare Costs in the US: A Retrospective Analysis of Claims Data of Patients Diagnosed Between 2017 and 2022

    Jun 1, 2024, 00:00

  • EE365 Empowering Access: Evaluating the Impact of Partnerships for Productive Development (PDP) on Access to Rituximab in Brazil

    Jun 1, 2024, 00:00

  • SA19 Mapping the Current Clinical Landscape for Alzheimer's Disease: A Qualitative Analysis

    Jun 1, 2024, 00:00

  • MSR62 Clinical Validation of an N-Gram Model for Detecting Economic Insecurity in Patient Populations Using Unstructured Clinical Notes

    Jun 1, 2024, 00:00

  • EE368 Claims-Based Comparison of Characteristics and Healthcare Costs Between Mothers With and Without Postpartum Depression

    Jun 1, 2024, 00:00

  • MSR91 Assessing Recall in Abstract Screening: Artificial Intelligence Vs. Human Reviewers

    Jun 1, 2024, 00:00

  • P38 Sources of Financial Support to Households Caring for Individuals with Duchenne Muscular Dystrophy: Results from a Caregiver Survey

    Jun 1, 2024, 00:00

  • EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • EE469 Societal Costs of Alzheimer's Disease: Informal Caregiver Burden and Patient Productivity Loss

    Jun 1, 2024, 00:00

  • RWD153 Best of Both Worlds: Enhancing Claims Data with Lab Results in Real-World Evidence Generation

    Jun 1, 2024, 00:00

  • HSD14 Characteristics of US Commercially Insured Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide

    Jun 1, 2024, 00:00

  • HPR10 Cell and Gene Therapy Access in the US and European Countries

    Jun 1, 2024, 00:00

  • EE86 Cost-Effectiveness of Tivozanib in Advanced Renal Cell Carcinoma in the US

    Jun 1, 2024, 00:00

  • EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan

    Jun 1, 2024, 00:00

  • SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease

    Jun 1, 2024, 00:00

  • EE499 Economic Burden of Prescription Opioid Abuse in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • SA57 A Comprehensive Search Filter to Identify Randomized Controlled Trials

    Jun 1, 2024, 00:00

  • EE425 A Comparison of Payer Costs for Patients with and without Revascularization in Thoracic Endovascular Aortic Repair Stent Grafting Procedures

    Jun 1, 2024, 00:00

  • MSR67 Modelling the Patient-Level Dependence of Overall Survival on Time to Objective Response in Oncology Studies Using Copulas

    Jun 1, 2024, 00:00

  • EE195 The Cost of Missing Physiotherapy Appointments

    Jun 1, 2024, 00:00

  • HSD11 Treatment Patterns and Healthcare Resource Utilization in Colombian Migraine Patients from 2018 to 2022

    Jun 1, 2024, 00:00

  • EE411 Cost-Effectiveness of Venetoclax in Combination with Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • SA11 Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR197 Health-related Quality of Life (HRQoL) Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR25 New Zealanders’ Preferences for Community Pharmacies: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • PCR135 Humanistic Burden of Fabry Disease and Associated Utility Values

    Jun 1, 2024, 00:00

  • HTA54 AMNOG Benefit Assessment in Germany: Outcomes from 2011 to November 2023

    Jun 1, 2024, 00:00

  • OP13 A Descriptive Analysis of Key Findings from the 2023-24 ISPOR Student Interest Survey

    Jun 1, 2024, 00:00

  • PCR183 Prevalence of Orthorexia Nervosa Among People on a Plant-Based Diet

    Jun 1, 2024, 00:00

  • Logical Inconsistencies With Expected Utility Theory May Align Better With Patient Preferences—A Response to Paulden et al

    Jun 1, 2024, 00:00

  • HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • HSD3 Implications of Non-Medical Switching in Medicare Part D: An Updated Review of the Literature

    Jun 1, 2024, 00:00

  • CO150 Efficiacy of Back School Program in Connection with Physical Activity Amongst Hungarian Adolescents

    Jun 1, 2024, 00:00

  • HTA Decisions and Deliberative Processes

    Jun 1, 2024, 00:00

  • MSR97 Indirect Estimation of Post-Distant Recurrence Survival (PDRS) for Resected Stage II/III Melanoma: A Network-Meta Analysis (NMA) Approach

    Jun 1, 2024, 00:00

  • Market Access on Availability and Use of Drugs

    Jun 1, 2024, 00:00

  • MSR103 Optimizing Systematic Literature Reviews in Endometrial Cancer: Leveraging AI for Real-Time Article Screening and Data Extraction in Clinical Trials

    Jun 1, 2024, 00:00

  • RWD168 Fractures in Adults Age Eighty and Older in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • SA60 The Use of Natural Language Processing in Literature Reviews

    Jun 1, 2024, 00:00

  • MSR48 Utilization of High-Dimensional Propensity Score and Targeted Maximum Likelihood Estimation with Machine Learning to Improve Causal Effect Estimation in Patients with Nonvalvular Atrial Fibrillation and Hypertension

    Jun 1, 2024, 00:00

  • EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

    Jun 1, 2024, 00:00

  • Economic Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • EE329 Budget Impact of Low-Dose Computed Tomography Screening for Lung Cancer in Argentina

    Jun 1, 2024, 00:00

  • MT5 Comparison of Outcomes of ePTFE Vascular Grafts With Heparin End-Point Covalent Bond and Alternative Autologous Vein for Below-Knee Surgical Bypass Procedures in Critical Limb Ischemia Patients

    Jun 1, 2024, 00:00

  • PCR136 Development of a Patient Preference Questionnaire Appropriate for Use with Potential Regimens for HIV Cure

    Jun 1, 2024, 00:00

  • RWD109 The Impact of the out-of-Pocket Cost of Insulin on Healthcare Resource Utilization and All Healthcare-Related Costs Using the Medical Expenditure Panel Survey 2016-2018

    Jun 1, 2024, 00:00

  • HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

    Jun 1, 2024, 00:00

  • EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Brazil: Results of a Global Survey

    Jun 1, 2024, 00:00

  • Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

    Jun 1, 2024, 00:00

  • PCR179 Manifestations and Comorbid Conditions Among Patients with Osteogenesis Imperfecta (OI): A US Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • Reviewer Acknowledgment

    Jun 1, 2024, 00:00

  • HPR85 Estimating the Income Elasticity of Abortion: A Cross-National Study of 99 Countries

    Jun 1, 2024, 00:00

  • HPR102 Trends in Specialty Pharmacy Use Among US Medicare Beneficiaries: Implications for Part D Policy

    Jun 1, 2024, 00:00

  • Award Winners

    Jun 1, 2024, 00:00

  • EPH206 Incidence and Risk Factors for Empiric Treatment Failure Among Females With Uncomplicated Urinary Tract Infections in an Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • HPR31 A Targeted Literature Review To Identify the Dimensions of Sustainable Global Biosimilars Markets

    Jun 1, 2024, 00:00

  • HPR131 The Risk of Osteoporotic Fractures in Elderly Asthmatic Patients According to Prescribing Patterns of Systemic Corticosteroid in South Korea

    Jun 1, 2024, 00:00

  • EE55 Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis

    Jun 1, 2024, 00:00

  • EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

    Jun 1, 2024, 00:00

  • EE331 Clinical and Health Outcomes Associated With Different Treatment Sequences for Moderate-to-Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • EPH74 Incidence and Lethality of Adult Pneumonia, Bacteremia, or Meningitis in Colombia From 2015 to 2022: A Retrospective, Database Study

    Jun 1, 2024, 00:00

  • HSD122 Medication Adherence, Persistence, and Treatment Switching in Patients Receiving Advanced Therapies for Rheumatoid Arthritis in Clinical Practice

    Jun 1, 2024, 00:00

  • CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

    Jun 1, 2024, 00:00

  • MSR19 Methods for Relaxing the Proportional Odds Assumption in Meta-Analysis of Aggregate Data

    Jun 1, 2024, 00:00

  • P28 Impact of FDA Expedited Review Programs on New Drug Approval Time

    Jun 1, 2024, 00:00

  • EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado

    Jun 1, 2024, 00:00

  • EE415 Cost of Hypoglycemia Among Hospitalized Patients With Diabetes Mellitus

    Jun 1, 2024, 00:00

  • EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States

    Jun 1, 2024, 00:00

  • PCR142 Qualitative Insights Into Disease Burden and Meaningful Change Associated With Cutaneous Neurofibromas (CNFs) in Adults With Neurofibromatosis Type 1

    Jun 1, 2024, 00:00

  • RWD121 Mental Health Outcomes and Treatments Utilized for Postpartum Depression Patients Hospitalized for a Mood Disorder in the US Using Real-World Data

    Jun 1, 2024, 00:00

  • RWD117 Unraveling Disparities in Right Heart Failure: A Comprehensive Analysis of Demographics, Socioeconomic Factors, and Mortality Predictors in a 117,633-Patient Cohort (2017-2020)

    Jun 1, 2024, 00:00

  • CO49 Progression of Chronic Kidney Disease Among Older Adults with Hypertension Using Group-Based Trajectory Modeling

    Jun 1, 2024, 00:00

  • HPR62 Analysis of FDA-Issued Warning Letters for Fraudulent Claims Within the Economic, Clinical, and Humanistic Outcomes (ECHO) Framework

    Jun 1, 2024, 00:00

  • EE21 Healthcare Resource Utilization Comparison of Balloon-Expandable Valve Versus Self-Expandable Valve for Transcatheter Aortic Valve Replacement in China

    Jun 1, 2024, 00:00

  • EPH44 Healthcare Expenditures Among Older Adult with Polypharmacy in the United States: A Propensity Score-Matched Cross-Sectional Study

    Jun 1, 2024, 00:00

  • EE120 Economic Burden of Pompe Disease in Colombia

    Jun 1, 2024, 00:00

  • EPH80 Outpatient Transfusions and Occurrence of Febrile Non-Hemolytic Transfusion Reactions Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022: Utility of Real-World Data

    Jun 1, 2024, 00:00

  • HSD76 A Systematic Literature Review (SLR) to Evaluate the Role of Socioeconomic Factors Associated with Treatment Practices Among Oncology Patients

    Jun 1, 2024, 00:00

  • EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador

    Jun 1, 2024, 00:00

  • CO64 Prevalence of Immunosuppressants and Antifibrotic Use in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

    Jun 1, 2024, 00:00

  • P26 Analyzing Drug Shortages and Pricing: Lessons from Canada

    Jun 1, 2024, 00:00

  • HSD27 Patterns of Postoperative Opioid Dispensing for Common Surgical Procedures Among Medicaid Beneficiaries in 2020-2021

    Jun 1, 2024, 00:00

  • EE341 A Comparison of Stapling Costs Used in Hybrid vs Robotic Surgery

    Jun 1, 2024, 00:00

  • HSD88 The Impact of Diagnosing Provider Type on Longitudinal Care for Patients With Newly Diagnosed Huntington’s Disease (HD)

    Jun 1, 2024, 00:00

  • EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States

    Jun 1, 2024, 00:00

  • Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review [Editor's Choice]

    Jun 1, 2024, 00:00

  • EPH81 Patient Characteristics and Health Care Resource Utilization of Cognitive Impairment Among Patients with Schizophrenia in the Veterans Affairs Administration System

    Jun 1, 2024, 00:00

  • OP12 Exploring Preferences in Selecting Dissertation Topics Among Ph.D. Students in Health Economics and Outcomes Research (HEOR) in the United States

    Jun 1, 2024, 00:00

  • EE324 Describing the Clinical and Economic Burden of Women Diagnosed With Uterine Fibroid (UF) and Heavy Menstrual Bleeding (HMB) in a United States (US) Commercial Database 2015-2022

    Jun 1, 2024, 00:00

  • EE112 Baricitinib in Alopecia Areata: A Budget Impact Analysis in Saudi Setting

    Jun 1, 2024, 00:00

  • PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan

    Jun 1, 2024, 00:00

  • CO74 Hospitalizations with Initiation of Hydroxychloroquine in Patients with Heart Failure with Preserved Ejection Fraction and Autoimmune Disease

    Jun 1, 2024, 00:00

  • EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • CO138 Impact of Steroid Withdrawal at Various Time Points After Liver Transplantation on Diabetes Mellitus: A Population-Based Cohort Study in South Korea

    Jun 1, 2024, 00:00

  • EPH45 Survey of Residents’ Perceptions and Concerns on Air Pollution in Maharashtra, India

    Jun 1, 2024, 00:00

  • EE32 Determining the Expected Pricing Advantage of First-in-Indication and First-in-Class Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • CO136 Unmet Treatment Needs in the Management of Patients With Eosinophilic Esophagitis: Insights From a Real-world Survey

    Jun 1, 2024, 00:00

  • EPH30 Real-World Adherence to Glycemic Self-Monitoring and Associated Factors Among Type 2 Diabetes Patients in Algeria: A Descriptive Cross-Sectional Study

    Jun 1, 2024, 00:00

  • MSR29 Application of a Novel Bayesian Dynamic Borrowing Approach Using Anonymized Finnish Real-World Data As an External Control Arm to Augment an Internal Control Arm of a Randomized Clinical Trial

    Jun 1, 2024, 00:00

  • HPR9 Racial and Ethnic Inequities in Endometrial Cancer Survival From 2017 to 2022: Assessing the Influence of Social Determinants of Health

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17 (current)
  • 18
  • 19
  • 20
  • »